In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 317-323

  Real, Luis Miguel ^a   Jimenez, Pilar ^a   Cantón, Julia ^a   Kirkin, Alexei ^b   García, Angel ^a   Abril, Eduardo ^a   Zeuthen, Jesper ^b   Ruiz Cabello, Francisco ^a   Garrido, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 6P; CHROMOSOME MAP; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HAPLOTYPE; HETEROZYGOSITY LOSS; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; MELANOMA; PRIORITY JOURNAL; TANDEM REPEAT; TUMOR ASSOCIATED LEUKOCYTE;

ALLELES; GENES, MHC CLASS I; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HUMANS; INTERFERON TYPE II; MELANOMA; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032545723     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<317::AID-IJC23>3.0.CO;2-8     Document Type: Article

References (28)

1. BODMER, W.F., BROWNING, M.J., KRAUSA, P., ROWAN, A., BICKNELL, D.C. and BODMER, J.G., Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N.Y. Acad. Sci., 690, 42-49 (1993).
2. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Immunol., 12, 337-365 (1994).
3. CABRERA, T., FERNANDEZ, M.A., SIERRA, A., GARRIDO, A., HERRUZO, A., ESCOBEDO, A., FABRA, A. and GARRIDO, F., High frequency of altered HLA-class-I phenotypes in invasive breast carcinomas. Hum. Immunol., 50, 127-134 (1996).
4. CAROSELLA, E.D., DAUSSET, J. and KIRSZENBAUM, M., HLA-G revisited. Immunol. Today, 17, 407-409 (1996).
5. D'ANDREA, A., CHANG, C., BACON, F., MCCLANAHAN, T., PHILIPS, J.H. and LANIER, L.L., Molecular cloning of NKB1. A natural-killer receptor for HLA-B allotypes. J. Immunol., 155, 2306-2310 (1995).
6. FELDMAN, M. and EISENBACH, L., MHC-class-I genes controlling metastatic phenotype of tumor cells. Semin. Cancer Biol., 2, 337-346 (1991).
7. GARRIDO, F., CABRERA, T., CONCHA, A., GLEW, S., RUIZ-CABELLO, F. and STERN, P., Natural history of HLA expression during tumor development. Immunol. Today, 14, 491-499 (1993).
8. GARRIDO, F., CABRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, F., HLA-class-I antigens in human tumors. Advanc. Cancer Res., 67, 155-195 (1995).
9. GARRIDO, F., RUIZ-CABELLO, F., CABRERA, T., PEREZ-VILLAR, J., LOPEZ-BOTET, M., DUGGAN-KEEN, M. and STERN, P.L., Implications for immuno-surveillance of altered HLA-class-I phenotypes in human tumours. Immunol. Today, 18, 89-95 (1997).
10. GYAPAY, G., MORISETTE, J., VIGNAL, A., DIB, C., FIZAMES, C., MILLASSEAU, P. MARC, S., BERNARDI, G., LATHROP, M. and WEISSENBACH, J., The 1993-1994 Genethon human genetic maps. Nature Genetics, 7, 246-249 (1994).
11. HARLOW, E. and LANE, D., Antibodies: a laboratory manual. Cold Spring Harbour Laboratory, New York (1988).
12. KAKLAMANIS, L. and HILL, A., MHC loss in colorectal tumours: evidence for immunoselection? Cancer surv., 13, 155 (1992).
13. KIRKIN, A.F., PETERSEN, T.R., OLSEN, A.C., PER THOR STRATEN, L.L. and ZEUTHEN, J., Generation of human-melanoma-specific T-lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother., 41, 71-81 (1995).
14. LEHMANN, F., MARCHAND, M., HAINAUT, P., SASTRE, X., IKEDA, H., BOON, T. and COULIE, P.G., Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Europ. J. Immunol., 25, 340-347 (1995).
15. MAJO, M. and PARMIANI, G., Melanoma immunotherapy: new dreams or solid hopes? Immunol. Today, 10, 405-407 (1996).
16. MARINCOLA, F.M., SHAMAMIAN, P., ALEXANDER, R.B., GNARRA, J.R., TURETSKAYA, R.L., NEDOSPASOV, S.A., SIMONIS, T.B., TAUBENBERGER, J.K., YANNELLI, J. and MIXON, A., Loss of HLA haplotype and B-locus down-regulation in melanoma cell lines. J. Immunol., 153, 1225-1237 (1994).
17. MARINCOLA, F.M., SHAMAMIAN, P., SIMONIS, T.B., ABATI, A., HACKETT, J., O'DEA, T., FETSCH, P., YANNELLI, J., RESTIFO, N.P., MULÉ, J.J. and ROSENBERG, S.A., Locus specific analysis of HLA class I expression in melanoma cell lines. J. Immunother., 19, 192-198 (1996).
18. MAROZZI, A., MENEVERI, R., DE SANTIS, C., ROBBIONI, P., MOLTENI, E., BERETTA, A., SICCARDI, A.G. and GINELLI, E., Expression of distinct conformations of free HLA-Cw4 heavy chains in transfected neuroblastoma cells. Immunogenetics, 43, 289-295 (1996).
19. MILLIKIN, D., MESSE, E., VOGELSTEIN, B., WITKOWSKI, C. and TRENT, J., Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res., 51, 5449-5453 (1991).
20. PELTENBURG, L.T.C. and SCHRIER, P.I., Transcriptional suppression of HLA-B expression by c-MYC is mediated through the core promoter elements. Immunogenetics, 40, 54-61 (1994).
21. ROBERTSON, G.P., COLEMAN, A.B. and LUGO, T.G., Mechanisms of human melanoma-cell growth and tumor suppression by chromosome. Cancer Res., 56, 1635-1641 (1996).
22. ROTH, C., ROCHLITZ, C. and KOURILSKY, P., Immune response against tumours. Advanc. Immunol., 57, 281-347 (1994).
23. TORRES, M.J., RUIZ-CABELLO, F., SKOUDY, A., BERROZPE, G., JIMENEZ, P., SERRANO, A., REAL, F.X. and GARRIDO, F., Loss of an HLA haplotype in cancer tissue and its corresponding tumour-derived cell line. Tissue Antigens. 47, 372-381 (1996).
24. THOR STRATEN, P., KIRKIN, A.F. SEREMET, T. and ZEUTHEN, J., Expression of transporter associated with antigen processing 1 and 2 (TAP 1/2) in malignant-melanoma cell lines. Int. J. Cancer, 70, 582-586 (1997).
25. TOWNSEND, A., OHLEN, C., BASTIN, J., LJUNGGREN, H.G., FOSTER, L. and KARRE, K., Association of class-I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond.), 340, 443-448 (1989).
26. VERSTEEG, R., PELTENBURG, L.T.C., PLOMP, A.C. and SCHRIER, P., High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J Immunol., 143, 4331-4338 (1989).
27. VESSIÈRE-LOUVEAUX, F., DARVILLE, M., KNUTH, A. and BOON, T., Use of irradiated mouse fibroblasts to improve the cloning and adaption to culture of human melanoma cells. Int. J. Cancer, 35, 231-237 (1985).
28. YOUNG, S., Population analysis of class-I-HLA antigen by one-dimensional iso-electric-focusing-gel electrophoresis: workshop summary report. In: B. Dupont (ed.), Immunobiology of HLA, Vol. 1, pp. 309-331, Springer, New York (1987).